4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001104659-21-129570
Options or other derivatives
- President of R&D and CMO acquired 157,058 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Huber Martin H. Jr. · President of R&D and CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +157,058 | 157,058 | D |
Loading xslF345X03/tm2130646-21_4seq1.xml…